by Sue Brown, CEO ARMA
Here we are back in lockdown, with the NHS under even more pressure and MSK services severely impacted. COVID-19 response is still dominating the work of ARMA, although we are also progressing plans for other work in 2021. There are some different issues for MSK this time around, and vaccination currently dominates our work. When some people with MSK conditions are vaccinated, the timings of MSK treatment may need to be considered.
I am delighted that ARMA can host a document setting out the principles for these timing decisions.…
Read more of this article